Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

Publisher： Karger

E-ISSN： 1664-5529|1|1|251-261

ISSN： 1664-5529

Source： Nephron Extra, Vol.1, Iss.1, 2011-12, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy

By  

Nephron, Vol. 135, Iss. 2, 2016-12 ,pp. : 87-96

Karger

Access to resources Recommend Favorite

Rituximab in Membranous Nephropathy: Not All Studies Are Created Equal

By  

Nephron, Vol. 135, Iss. 1, 2016-09 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

By  

Nephron, Vol. 130, Iss. 3, 2015-06 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Effective Treatment of Idiopathic Membranous Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 507-508

Karger

Access to resources Recommend Favorite

Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations


By  

Nephron Extra, Vol. 7, Iss. 1, 2017-02 ,pp. : 1-9

Karger

Access to resources Recommend Favorite